- Home
- GTEC vs LSTA Comparison
GTEC vs LSTA Comparison
Compare GTEC & LSTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GTEC
- LSTA
- Stock Information
- Founded
- GTEC 2006
- LSTA 1980
- Country
- GTEC United States
- LSTA United States
- Employees
- GTEC N/A
- LSTA N/A
- Industry
- GTEC Industrial Machinery/Components
- LSTA Misc Health and Biotechnology Services
- Sector
- GTEC Industrials
- LSTA Health Care
- Exchange
- GTEC Nasdaq
- LSTA Nasdaq
- Market Cap
- GTEC 18.2M
- LSTA 20.0M
- IPO Year
- GTEC N/A
- LSTA N/A
- Fundamental
- Price
- GTEC $1.26
- LSTA $2.32
- Analyst Decision
- GTEC
- LSTA Strong Buy
- Analyst Count
- GTEC 0
- LSTA 1
- Target Price
- GTEC N/A
- LSTA $15.00
- AVG Volume (30 Days)
- GTEC 125.2K
- LSTA 17.8K
- Earning Date
- GTEC 04-15-2025
- LSTA 05-08-2025
- Dividend Yield
- GTEC N/A
- LSTA N/A
- EPS Growth
- GTEC N/A
- LSTA N/A
- EPS
- GTEC N/A
- LSTA N/A
- Revenue
- GTEC $87,352,614.00
- LSTA $1,000,000.00
- Revenue This Year
- GTEC N/A
- LSTA N/A
- Revenue Next Year
- GTEC $1.70
- LSTA N/A
- P/E Ratio
- GTEC N/A
- LSTA N/A
- Revenue Growth
- GTEC 0.76
- LSTA N/A
- 52 Week Low
- GTEC $1.25
- LSTA $2.05
- 52 Week High
- GTEC $2.94
- LSTA $4.20
- Technical
- Relative Strength Index (RSI)
- GTEC 28.39
- LSTA 42.12
- Support Level
- GTEC $1.28
- LSTA $2.07
- Resistance Level
- GTEC $1.38
- LSTA $2.62
- Average True Range (ATR)
- GTEC 0.15
- LSTA 0.21
- MACD
- GTEC -0.02
- LSTA 0.01
- Stochastic Oscillator
- GTEC 1.59
- LSTA 47.37
About GTEC Greenland Technologies Holding Corporation
Greenland Technologies Holding Corp is a developer of quality solutions in the material handling industry. It is a transmission and drivetrain systems provider for material handling equipment such as forklift trucks for industrial and logistic applications. Geographically, the company has its presence in Domestic and International markets and earns majority of the revenue from Domestic Sales.
About LSTA Lisata Therapeutics Inc.
Lisata Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative therapies for the treatment of advanced solid tumors and other major diseases. Its product candidate, LSTA1, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively.